Weiwei Xue
Orcid: 0000-0002-3285-0574
According to our database1,
Weiwei Xue
authored at least 25 papers
between 2012 and 2024.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
On csauthors.net:
Bibliography
2024
Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.
J. Chem. Inf. Model., March, 2024
Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine.
J. Chem. Inf. Model., February, 2024
MoDAFold: a strategy for predicting the structure of missense mutant protein based on AlphaFold2 and molecular dynamics.
Briefings Bioinform., January, 2024
CNSMolGen: A Bidirectional Recurrent Neural Network-Based Generative Model for De Novo Central Nervous System Drug Design.
J. Chem. Inf. Model., 2024
OPTICS: An interactive online platform for photosensory and bio-functional proteins in optogenetic systems.
Comput. Biol. Medicine, 2024
DTNPD: A comprehensive database of drugs and targets for neurological and psychiatric disorders.
Comput. Biol. Medicine, 2024
2023
Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein docking.
Comput. Biol. Medicine, September, 2023
Structure-Based Discovery of a Novel Allosteric Inhibitor against Human Dopamine Transporter.
J. Chem. Inf. Model., July, 2023
Unbiased molecular dynamics simulation of a first-in-class small molecule inhibitor binds to oncostatin M.
Comput. Biol. Medicine, March, 2023
2022
Nucleic Acids Res., 2022
Earth Sci. Informatics, 2022
2021
Nucleic Acids Res., 2021
J. Chem. Inf. Model., 2021
2020
Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data.
Briefings Bioinform., 2020
A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.
Briefings Bioinform., 2020
A critical assessment of the feature selection methods used for biomarker discovery in current metaproteomics studies.
Briefings Bioinform., 2020
ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies.
Briefings Bioinform., 2020
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
Briefings Bioinform., 2020
Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning.
Briefings Bioinform., 2020
Convolutional neural network-based annotation of bacterial type IV secretion system effectors with enhanced accuracy and reduced false discovery.
Briefings Bioinform., 2020
Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data.
Briefings Bioinform., 2020
2017
Nucleic Acids Res., 2017
2014
Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis.
J. Chem. Inf. Model., 2014
2013
Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis.
J. Chem. Inf. Model., 2013
2012
Molecular mechanism of HIV-1 integrase-vDNA interactions and strand transfer inhibitor action: A molecular modeling perspective.
J. Comput. Chem., 2012